Concepedia

Author

Giorgio Bolis

University of MilanORCID

Also Known As

Bolis G, G BOLIS, G Bolis, G. BOLIS, G. Bolis, GIORGIO BOLIS, Giorgio Bolis, U Bianchi, Varon, D

202

Publications

9.2K

Citations

44

H-Index

150

Concepts

All Affiliations

University of MilanFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoMario Negri Institute for Pharmacological ResearchFondazione IRCCS Istituto Nazionale dei TumoriLeiden University Medical Center
GB

About

Giorgio Bolis is an author at University of Milan specializing in medicine, obstetrics, and ovarian cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

29

59

3.1K

2

Engineering

8

8

392

3

Natural Sciences

5

5

123

4

Arts

1

1

20

5

Health Sciences

1

1

271

Giorgio Bolis

×

104

Publications

8K

Citations

43

H-Index

YearCitations

Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.

W ten Bokkel Huinink, Martin Gore, J Carmichael,

Journal of Clinical Oncology

1997

681

A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer Surgery

Giancarlo Agnelli, Giorgio Bolis, Lorenzo Capussotti,

Annals of Surgery

2005

680

Impact of Adjuvant Chemotherapy and Surgical Staging in Early-Stage Ovarian Carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm Trial

J. Baptist Trimbos, Ignace Vergote, Giorgio Bolis,

JNCI Journal of the National Cancer Institute

2003

679

Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study.

G.J. Creemers, Giorgio Bolis, M. Gore,

Journal of Clinical Oncology

1996

386

Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel.

M. A. Bookman, Henric Malmström, Giorgio Bolis,

Journal of Clinical Oncology

1998

334

Chemotherapy in advanced ovarian cancer: An overview of randomised clinical trials

Lesley Stewart, Kristian Aabo, P I Adnitt,

1991

271

Vitamin D Protects Human Endothelial Cells From Oxidative Stress Through the Autophagic and Survival Pathways

Francesca Uberti, D. Lattuada, Vera Morsanuto,

The Journal of Clinical Endocrinology & Metabolism

2013

233

Randomised Comparison of Cisplatin with Cyclophosphamide/Cisplatin and with Cyclophosphamide/Doxorubicin/Cisplatin in Advanced Ovarian Cancer

Giorgio Bolis

Obstetrical & Gynecological Survey

1988

218

Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group

Matti Aapro, F.H. van Wijk, Giorgio Bolis,

Annals of Oncology

2003

200

Regression of Advanced Ovarian Carcinoma by Intraperitoneal Treatment With Autologous TLymphocytes Retargeted by a Bispecific Monoclonal Antibody

Silvana Canevari, Gerrit Stoter, Flavio Arienti,

JNCI Journal of the National Cancer Institute

1995

191

Page 1